In 2018, a number of Korean pharma medicines expected to acquire approval from U.S. FDA
In 2018, there is a high expectation on the Korean pharmaceutical industry. Along with recent technology exports to other countries, it has been expected there would be a number of products to emerge as a medicine to enter advanced markets, like U.S.
△ Series of technology exports; 3 cases in a ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
